In the past week, LFST stock has gone down by -3.02%, with a monthly decline of -15.43% and a quarterly plunge of -6.65%. The volatility ratio for the week is 3.34%, and the volatility levels for the last 30 days are 4.24% for LifeStance Health Group Inc The simple moving average for the last 20 days is -9.98% for LFST’s stock, with a simple moving average of -0.25% for the last 200 days.
Is It Worth Investing in LifeStance Health Group Inc (NASDAQ: LFST) Right Now?
The 36-month beta value for LFST is at 1.29. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for LFST is 109.64M, and currently, shorts hold a 7.66% of that float. The average trading volume for LFST on March 19, 2025 was 1.43M shares.
LFST) stock’s latest price update
The stock of LifeStance Health Group Inc (NASDAQ: LFST) has decreased by -2.18 when compared to last closing price of 6.89.Despite this, the company has seen a loss of -3.02% in its stock price over the last five trading days. seekingalpha.com reported 2025-02-28 that LifeStance Health Group, Inc. (NASDAQ:LFST ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Monica Prokocki – VP, IR Ken Burdick – CEO David Bourdon – CFO Conference Call Participants Craig Hettenbach – Morgan Stanley Lisa Gill – JPMorgan Jamie Perse – Goldman Sachs Brian Tanquilut – Jefferies Andrea Alfonso – UBS Operator Thank you for standing by. My name is Danielle, and I will be your conference operator today.
Analysts’ Opinion of LFST
Many brokerage firms have already submitted their reports for LFST stocks, with Goldman repeating the rating for LFST by listing it as a “Buy.” The predicted price for LFST in the upcoming period, according to Goldman is $10 based on the research report published on December 16, 2024 of the previous year 2024.
Barclays, on the other hand, stated in their research note that they expect to see LFST reach a price target of $7. The rating they have provided for LFST stocks is “Underweight” according to the report published on January 03rd, 2024.
TD Cowen gave a rating of “Market Perform” to LFST, setting the target price at $9 in the report published on May 15th of the previous year.
LFST Trading at -13.11% from the 50-Day Moving Average
After a stumble in the market that brought LFST to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.72% of loss for the given period.
Volatility was left at 4.24%, however, over the last 30 days, the volatility rate increased by 3.34%, as shares sank -15.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.73% lower at present.
During the last 5 trading sessions, LFST fell by -3.02%, which changed the moving average for the period of 200-days by +19.50% in comparison to the 20-day moving average, which settled at $7.49. In addition, LifeStance Health Group Inc saw -8.55% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LFST starting from Miller Lisa K, who sale 18,845 shares at the price of $6.90 back on Mar 17 ’25. After this action, Miller Lisa K now owns 339,810 shares of LifeStance Health Group Inc, valued at $130,030 using the latest closing price.
Miller Lisa K, the Officer of LifeStance Health Group Inc, proposed sale 18,845 shares at $6.90 during a trade that took place back on Mar 17 ’25, which means that Miller Lisa K is holding shares at $129,993 based on the most recent closing price.
Stock Fundamentals for LFST
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.29 for the gross margin
The net margin for LifeStance Health Group Inc stands at -0.05. The total capital return value is set at -0.02. Equity return is now at value -4.00, with -2.58 for asset returns.
Based on LifeStance Health Group Inc (LFST), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at 0.54. The debt to equity ratio resting at 0.14. The interest coverage ratio of the stock is -1.17.
Currently, EBITDA for the company is 39.87 million with net debt to EBITDA at 1.09. When we switch over and look at the enterprise to sales, we see a ratio of 2.11. The receivables turnover for the company is 9.48for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.37.
Conclusion
In conclusion, LifeStance Health Group Inc (LFST) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
